Low-grade Non-hodgkin Lymphoma

• CLINICAL_TRIALS research · 2025-07-31
  Clinical Trial Update: 64Cu-LLP2A for Imaging Hematologic Malignancies [EARLY_Phase 1]

  Phase 1 imaging trial evaluating 64Cu-LLP2A in hematologic malignancies is currently recruiting, targeting multiple myeloma and various lymp…

• CLINICAL_TRIALS research · 2013-12-18
  Clinical Trial Update: Beta Alethine in Treating Patients With Low-Grade Lymphoma [Phase 1, Phase 2]

  This clinical trial update covers the Phase 1/Phase 2 study of Beta Alethine in patients with low-grade non-Hodgkin lymphoma.

• CLINICAL_TRIALS research · 2009-09-30
  Clinical Trial Update: Rituxan Plus FavId (Idiotype Vaccine) for Low-grade Non-Hodgkin's Lymphoma [Phase 2]

  This update describes a Phase 2 trial evaluating Rituxan plus FavId idiotype vaccine for low-grade non-Hodgkin lymphoma. The current status …